Effect of glycine in streptozotocin-induced diabetic rats

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 134, Issue 4, 2003, Pages 521-527

  Alvarado Vásquez, Noé ^a   Zamudio, Pedro ^a   Cerón, Eduarda ^a   Vanda, Beatriz ^b   Zenteno, Edgar ^c   Carvajal Sandoval, Guillermo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Diabetes mellitus; Glucose; Glycine; Hypercholesterolemia; Hyperlipidemia; Hypertriacylglycerolemia; Non enzymatic glycation; Taurine

Indexed keywords

CHOLESTEROL; GLYCINE; GLYCOSYLATED HEMOGLOBIN; TAURINE; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL VACUOLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS NECROSIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0242417162     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(03)00046-2     Document Type: Article

References (33)

1. Alvarado-Vasquez, N., 1999. Neurological, biochemical and morphologic analysis of a model of diabetic rat type I treated with glycine or taurine. MS Thesis, Facultad de Ciencias, UNAM, México.
2. Anderson R.A., Evans M.L., Ellis G.R., Graham J., Morris K., Jackson S.K., Lewis M.J., Rees A., Frenneaux M.P. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis. 154:2001;475-483.
3. Bellomo G., Maggi E., Poli M. Autoantibodies against oxidatively modified low density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
4. Carvajal-Sandoval G., Juárez de Carvajal E., Ramos M. G., Carvajal-Juárez M.E. Inhibition of non-enzymatic glycosylation of haemoglobin in diabetes mellitus. Rev. Inst. Nal. Enf. Resp. Mex. 8:1995;185-188.
5. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet. Med. 14:(suppl 3):1997;S45-S49.
6. Dezna C., Sheehan H.B.B. Theory and practice of histotechnology. Second Edition:1980;C.V Mosby Company, St. Louis, MO, USA.
7. Diaz N.N., Frei B., Vita J.A. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:1997;408-416.
8. Giugliano D., Ceriello A., Paolisso G. Oxidative stress in diabetic vascular complications. Diabetes Care. 19:1996;257-267.
9. Gonzales-Ortiz M., Medina-Santillan R., Martinez-Abundis E., von Drateln C.R. Effect of glycine on insulin secretion and action in healthy first-degree relatives of type 2 diabetes mellitus patients. Horm. Metab. Res. 33:2001;358-360.
10. Goodman H.O., Shihabi Z.K. Supplemental taurine in diabetic rats: Effects on plasma glucose and triglycerides. Biochem. Med. Metabol. Biol. 43:1990;1-9.
11. Hee-Sook J., Hak Y.B., Byoung R.L., Kwang S.K., Young S.K., Kwan W.L., Hyun-man K., JiWon Y. Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM)- genetic predisposition and metabolic abnormalities. Adv. Drug. Deliver. Rev. 35:1999;157-177.
12. Higgins J.P., Bunn F.H. Kinetic analysis of the non-enzymatic glycosylation of haemoglobin. J. Biol. Chem. 256:1981;5204-5208.
13. Kim A.J., Berliner A.J., Natarajan R.D., Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 43:1994;1103-1107.
14. Kim H.G., Une M., Kuramoto T., Noshiro M., Fujimura K. Hypocholesterolemic effect of bile acid sulfonate analogs in hamsters. Biol. Pharm. Bull. 24:2001;218-220.
15. Kirpichnikov D., Sowers J.R. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol. Metabolism. 12:2001;225-230.
16. Marsh C.D., Vreugdenhil K.P., Mack E.V., Belzer O.F., Southard H.J. Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology. 17:1992;91-98.
17. Maturo J., Kulakowski C.E. Insulin-like activity of taurine. Adv. Exp. Med. Biol. 217:1987;217-226.
18. Mendez J.D., Ramos G.H.B. Animal models in diabetes research. Arch. Med. Res. 25:1994;367-375.
19. Menzel E.J., Reihsner R. Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine. Diabetologia. 34:1991;12-16.
20. Nakamura T., Ogasawara M., Koyama Y., Nemoto M., Yoshida T. The protective effect of taurine on the biomembrane against damage produced by oxygen radicals. Biol. Pharma. Bull. 16:1993;970-972.
21. Nakaya Y., Minami A., Harada N., Sakamoto S., Niwa Y., Ohnaka M. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneously type 2 diabetes. Am. J. Clin. Nutr. 71:2000;54-58.
22. O′Brien T., Nguyeen T.T., Zimmerman B.R. Hyperlipidaemia Diabetes Mellitus. Mayo Clinic Proceedings. 73:1998;969.
23. Ogasawara M., Nakamura T., Koyama Y., Nemoto M., Yoshida T. Reactivity of taurine with aldehydes and its physiological role. Adv. Exp. Med. Biol. 359:1994;71-78.
24. Ogawa H. Effect of dietary taurine on lipid metabolism in normcholesterolemic and hypercholesterolemic stroke-prone spontaneously hypertensive rats. Adv. Exp. Med. Biol. 43:1996;107-115.
25. Ramakrishnan S., Sulochana K.N. Decrease in glycation of lens proteins by lysine and glycine by scavenging of glucose and possible mitigation of cataractogenesis. Exp. Eye. Res. 57:1993;623-628.
26. Sensi M., De Ross G.M., Celi F.S., Cristina A., Rosati C., Perrett D. D-lysine reduces the non-enzymatic glycation of proteins in experimental diabetes mellitus in rats. Diabetologia. 36:1993;797-801.
27. Taniguchi N., Kaneto H., Asahi M. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 46:1998;581-583.
28. Taniguchi N., Kaneto H., Asahi M., Takahashi M., Wenyi Che., Higashiyama S., Fujii J., Suzuki K., Kayanoki Y. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 45:(Suppl 3):1996;S81-S83.
29. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A., Tarectecan A.A., Rao P.S., Sturman J.A., Boles T.H. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269:1995;F429-438.
30. Wolffenbuttel B.H., Giordano D., Founds H.W., Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet. 347:1996;513-515.
31. Xu G., Salen G., Shefer S., Ness G.C., Nguyen L.B., Tint G.S., Parker T.S., Roberts J., Batta A.K., Chen T.S., Zhao Z., Kong X. Increasing hepatic cholesterol 7α-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits. Hepatology. 24:1996;882-887.
32. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyahi F., Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J. Nutr. 129:1999;1705-1712.
33. Ziegler D. The design of clinical trials for treatment of diabetic neuropathy. Neurosci. Res. Commun. 21:1997;83-91.